title: Oestrogen redux: will transdermal delivery rebalance the risk-benefit equation?
authors.affiliation: Eastern Virginia Medical School, Urology of Virginia, Virginia Beach, VA, USA.
authors.forename: Paul F
authors.initials: PF
authors.lastname: Schellhammer
mesh_terms: D000279:Administration, Cutaneous; D004967:Estrogens; D006801:Humans; D018570:Risk Assessment
chemical_list: D004967:Estrogens